Isoniazid preventive therapy for HIV-infected people: evidence to support implementation
Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme
Why have trials of isoniazid preventive therapy among people with HIV infection not demonstrated an effect on mortality?
Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening
Adverse events with isoniazid preventive therapy: experience from a large trial
‘Team up against TB’: promoting involvement in Thibela TB, a trial of community-wide tuberculosis preventive therapy
Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study
The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) Study
Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions